María E. Riveiro
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- Protein Degradation and Inhibitors 23
- Histone Deacetylase Inhibitors Research 8
- Cancer-related gene regulation 7
- Ubiquitin and proteasome pathways 4
- Hematology 11
- Multiple Myeloma Research and Treatments 10
- Co-authors
- Lucile Astorgues‐Xerri (13 shared papers)Esteban Cvitkovic (18 shared papers)Éric Raymond (14 shared papers)Carina Shayo (10 shared papers)Carlos Davio (10 shared papers)Ramiro Vázquez (16 shared papers)Sandrine Faivre (10 shared papers)Maria Serova (10 shared papers)
- Journals
- Cancer Research (9 papers)Blood (6 papers)Oncotarget (5 papers)Bioorganic & Medicinal Chemistry (3 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- FranceItalySwitzerland
In The Last Decade
María E. Riveiro
47 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 88
- Hematology 335
- Molecular Biology 1.1k
- Immunology 311
- Oncology 284
- Cancer Research 131
Countries citing papers authored by María E. Riveiro
This map shows the geographic impact of María E. Riveiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María E. Riveiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María E. Riveiro more than expected).
Fields of papers citing papers by María E. Riveiro
This network shows the impact of papers produced by María E. Riveiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María E. Riveiro. The network helps show where María E. Riveiro may publish in the future.
Co-authors
The 25 scholars most cited alongside María E. Riveiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 219 | |
| 2 | 2015 | 212 | |
| 3 | 2013 | 183 | |
| 4 | 2007 | 154 | |
| 5 | 2016 | 124 | |
| 6 | 2014 | 104 | |
| 7 | 2016 | 82 | |
| 8 | 2015 | 73 | |
| 9 | 2016 | 50 | |
| 10 | 2004 | 45 | |
| 11 | 2012 | 40 | |
| 12 | 2009 | 39 | |
| 13 | 2013 | 38 | |
| 14 | 2013 | 37 | |
| 15 | 2003 | 36 | |
| 16 | 2007 | 31 | |
| 17 | 2012 | 29 | |
| 18 | 2008 | 29 | |
| 19 | 2021 | 28 | |
| 20 | 2016 | 28 |
About María E. Riveiro
María E. Riveiro is a scholar working on Molecular Biology, Hematology, Oncology, Cancer Research and Pharmacology, having authored 48 papers that have together received 1.8k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (23 papers), Multiple Myeloma Research and Treatments (10 papers), Histone Deacetylase Inhibitors Research (8 papers), Cancer-related gene regulation (7 papers), Synthesis of Organic Compounds (6 papers), Plant chemical constituents analysis (5 papers), Ubiquitin and proteasome pathways (4 papers) and Galectins and Cancer Biology (4 papers). The work is most often cited by research in Hematology (335 citations), Molecular Biology (1.1k citations), Immunology (311 citations), Oncology (284 citations) and Cancer Research (131 citations). María E. Riveiro has collaborated with scholars based in France, Italy and Switzerland. Frequent co-authors include Lucile Astorgues‐Xerri, Esteban Cvitkovic, Éric Raymond, Carina Shayo, Carlos Davio, Ramiro Vázquez, Sandrine Faivre, Maria Serova, Annemilaï Tijeras‐Raballand and Patrice Herait. Their work appears in journals such as Cancer Research, Blood, Oncotarget, Bioorganic & Medicinal Chemistry and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.